USA authorized SynoCell retailer2 capsules a day · 60 per bottleFree standard U.S. shipping90-day money-back policy
Order now

Research news

The 2026 ACR osteoarthritis guideline: what changed, and what it means for supplement buyers

Quick answer

The American College of Rheumatology approved a 2026 summary on September 8, 2026. Exercise, weight loss and NSAIDs stay strongly recommended. Tai chi drops to conditional. Glucosamine, chondroitin and combination products are strongly advised against, and fish oil, vitamin D and injected hyaluronic acid conditionally against. ASU and Boswellia are not addressed. The full paper is not yet published.

Written by the SynoCell editorial teamUpdated · 8 min read

A single white SynoCell bottle with a teal wave label and gold medallion
SynoCell contains none of the supplements the 2026 summary advises against. Its main ingredients are simply not addressed.

What is the 2026 ACR osteoarthritis guideline?

It is the American College of Rheumatology's updated advice for treating osteoarthritis of the knee, hip and hand. The summary was approved on September 8, 2026 (ACR, 2026 OA guideline summary).

It replaces the 2019 guideline written with the Arthritis Foundation (Kolasinski et al., 2020 (ACR/AF 2019 guideline)). That matters to a lot of people: about 33 million U.S. adults have osteoarthritis (CDC, Osteoarthritis).

Only the summary is out

The ACR has released an approved summary of recommendations. The full manuscript, with the evidence tables and reasoning, is still pending.

What changed between the 2019 and 2026 guidelines?

Most core advice held steady. The big moves were tai chi, a wider "no" for glucosamine-style products, and new advice against fish oil and vitamin D.

2019 ACR/Arthritis Foundation guideline versus the 2026 ACR summary for knee, hip and hand osteoarthritis.
Treatment2019 guideline (Kolasinski et al., 2020 (ACR/AF 2019 guideline))2026 summary (ACR, 2026 OA guideline summary)
ExerciseStrongly forStrongly for
Weight loss, knee or hip, if overweightStrongly for, at least 5% of body weightStrongly for
Tai chiStrongly for, knee and hipConditional
Topical NSAIDsStrongly for, kneeStrongly for, knee and hand
Oral NSAIDsStrongly forStrongly for
GlucosamineStrongly againstStrongly against
ChondroitinStrongly against, knee and hipStrongly against
Combination productsNot named in our 2019 source notesStrongly against
Fish oil, vitamin DNot named in our 2019 source notesConditionally against
Hyaluronic acid injectionsConditionally against, knee; strongly against, hipConditionally against
ASU, Boswellia, curcuminNot addressedNot addressed

Why did tai chi move to a conditional recommendation?

The summary does not say why. The full paper should explain the evidence behind the change.

A conditional rating does not mean tai chi is bad. It means the benefit is less certain, or depends more on the person, so the choice is shared with your clinician. If tai chi helps you move and you enjoy it, keep going. Exercise in general remains strongly recommended.

What does the guideline say about glucosamine and chondroitin?

It strongly recommends against them, alone or in combination products (ACR, 2026 OA guideline summary). That is the firmest "no" a guideline can give.

Many joint supplements are built around these two ingredients. If yours is, the 2026 summary is a good reason to talk with your doctor before buying another bottle.

  • Check the Supplement Facts for glucosamine sulfate, glucosamine HCl or chondroitin sulfate.
  • Fish oil and vitamin D taken for joints now get a conditional "no" as well.

Where do ASU, Boswellia and oral hyaluronic acid fit?

The summary does not address ASU, Boswellia or curcumin (ACR, 2026 OA guideline summary). Not addressed is not the same as recommended. It means the panel did not rate them either way.

  1. Exercise

    Strong

    Strongly recommended by the American College of Rheumatology for knee, hip and hand osteoarthritis. (ACR, 2026 OA guideline summary) (Kolasinski et al., 2020 (ACR/AF 2019 guideline))

  2. Weight loss (if overweight)

    Strong

    Each pound lost takes about four pounds of load off the knee; strongly recommended for knee and hip OA. (Messier et al., 2005) (ACR, 2026 OA guideline summary)

  3. Topical or oral NSAIDs

    Strong

    Strongly recommended, with heart, stomach and kidney risks to discuss with a doctor. (ACR, 2026 OA guideline summary) (FDA, 2015 NSAID safety communication)

  4. Avocado/soybean unsaponifiables

    Small

    Four trials: pain about 8.5 points lower on a 0-100 scale, a benefit of questionable importance. (Cameron and Chrubasik, 2014)

  5. Boswellia extracts

    Small trials

    Seven small trials, 545 patients, mostly positive; different extracts from SynoCell's. (Yu et al., 2020)

  6. Oral hyaluronic acid

    Mixed

    Small studies; one 12-month trial helped only people aged 70 or younger. (Tashiro et al., 2012) (Guadagna et al., 2018)

  7. Glucosamine and chondroitin

    Advised against

    The 2026 ACR guideline strongly recommends against them for knee, hip and hand OA. (ACR, 2026 OA guideline summary)

  8. Quercetin for joints

    No human trials

    Only animal and lab data for osteoarthritis. (MSKCC, Quercetin)

Bar length shows how much published evidence supports each option for osteoarthritis pain and function, based on the guideline and reviews linked here. A reading aid, not a score from any one source.

The hyaluronic acid advice covers injections into the knee, not capsules. Swallowed hyaluronic acid has its own small studies, with mixed results (Guadagna et al., 2018). Read more in our oral HA versus injections article.

Try SynoCell with a 90-day window2 capsules a day · from $39 a bottle · free standard U.S. shipping

Order now

What should supplement buyers do after the 2026 update?

Start with what has strong support, then decide whether a supplement is worth adding.

  1. Move every day

    Exercise is strongly recommended for knee, hip and hand osteoarthritis.

  2. Lose weight if you carry extra

    Each pound lost takes about 4 pounds of load off the knee (Messier et al., 2005). In the IDEA trial, diet plus exercise with 11.4% weight loss beat exercise alone (Messier et al., 2013 (IDEA trial)).

  3. Use pain relievers wisely

    NSAID heart and stroke risk can start in the first weeks, so use the lowest dose for the shortest time (FDA, 2015 NSAID safety communication).

  4. Skip what the ACR advises against

    That now includes glucosamine, chondroitin, combinations, fish oil and vitamin D for joints.

  5. Judge any other supplement on its label

    Use our buyer's checklist and ask your pharmacist about interactions.

Where does SynoCell stand under the new guideline?

SynoCell contains none of the supplements the summary advises against. It has no glucosamine, chondroitin, fish oil or vitamin D.

Its main ingredients, ASU, Boswellia and oral hyaluronic acid, sit in the not-addressed group. ASU and hyaluronic acid are printed at amounts near those used in small trials (Cameron and Chrubasik, 2014) (Oe et al., 2016). Quercetin has no human osteoarthritis trials (MSKCC, Quercetin), and no trial has tested the SynoCell blend itself.

That is a fair but modest position. SynoCell is a supplement, not a treatment for arthritis, and the guideline's strong advice still comes first. See every amount on our ingredients page.

What happens when the full ACR paper is published?

We will read it and update this article. The full paper should give the reasons and the studies weighed.

Until then, treat the summary as the current word, and check with your doctor before stopping or starting anything.

FAQ

Questions about the 2026 ACR osteoarthritis guideline

What is the new ACR guideline for osteoarthritis in 2026?

It is the American College of Rheumatology's updated advice for knee, hip and hand osteoarthritis, approved as a summary on September 8, 2026. It strongly recommends exercise, weight loss if overweight and NSAIDs, and advises against glucosamine, chondroitin, fish oil and vitamin D. The full paper is still pending.

Is tai chi still recommended for knee osteoarthritis?

Yes, but now conditionally. The 2019 guideline strongly recommended tai chi for knee and hip osteoarthritis; the 2026 summary rates it conditional, meaning the choice depends more on the person. Exercise in general is still strongly recommended, so tai chi remains a reasonable option if you enjoy it.

Does the 2026 ACR guideline recommend glucosamine for knee arthritis?

No. The 2026 summary strongly recommends against glucosamine, chondroitin and products that combine them, for knee, hip and hand osteoarthritis. That is the firmest negative rating a guideline gives. Talk with your doctor if you take one now, and look at exercise and weight loss first.

Does the ACR recommend fish oil or vitamin D for arthritis?

No. The 2026 summary conditionally recommends against fish oil and vitamin D for osteoarthritis. If a doctor prescribed either one for another reason, keep taking it and ask before you change anything.

Are hyaluronic acid injections recommended for knee osteoarthritis in 2026?

The 2026 summary conditionally recommends against hyaluronic acid injections. That rating is about shots into the joint. Hyaluronic acid swallowed in capsules is a different product with its own small studies, and the summary does not rate oral forms.

Does the ACR guideline mention Boswellia or ASU?

No. The 2026 summary does not address Boswellia, avocado/soybean unsaponifiables or curcumin, and the 2019 guideline did not either. Not addressed is not the same as recommended. Small trials suggest modest pain benefits for both, so judge any product by its dose and extract.

When will the full 2026 ACR osteoarthritis guideline be published?

The ACR has released only the approved summary; the full manuscript is pending, and no publication date appears in the summary. We will update this article when the paper comes out, since it should explain the reasons behind each rating.

Who wrote this

Written and reviewed by

Written byThe SynoCell editorial teamSynocell, USA authorized SynoCell retailer

Plain-language pages built from the label, the brand store and linked medical sources.

Medical review byDr. Nehad Soloman, MD, FACR, MD, PhysicianRole: Medical reviewerReview date: October 12, 2026

Last updated . Read our editorial standards and how we check reviews. This website is run by an authorized U.S. retailer, not by the manufacturer. We earn money when you buy through our order links.

USA authorized SynoCell retailer

Ready to try SynoCell?

Pick a pack. Two capsules a day, and the 90-day money-back policy gives you three months to decide.

  • Secure checkout
  • 90-day money-back policy
  • Ships from the U.S. with tracking
A white bottle of SynoCell capsules with a teal label

SynoCell capsulesFrom $39 a bottle · free standard U.S. shipping · 90-day window

Order now